Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs low molecular weight heparin in thrombolytic therapy for acute lower-extremity DVT
ChiCTR2300068895Phase 3Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of bivalirudin in deep vein thrombosis (DVT) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: thrombolysis rate, diameter of the legs and 3 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
bivalirudin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR2300068895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068895.